Answers are grounded in this paper and cite their sources.
During the first outbreak of COVID-19 in the spring of 2020 different symptoms of the disease were reported. Therefore, this study aimed to evaluate initial neurological symptoms of COVID-19 among hospitalized patients in that time period. In patients with confirmed COVID-19, initial symptoms, concomitant diseases, neurological signs, and neurological status were assessed. Sixty-six patients (mean age 63 years) were prospectively enrolled, 44 (66.7%) of them were males. Initial neurological symptoms were reported by 51 (77.3%), most commonly headache (14 [21.2%]), dizziness, and vertigo (14 [21.2%]). Dysgeusia was present in 13 (19.7%) and anosmia in 10 (15.2%) patients. Initial neurological symptoms were observed in 20 (76.9%) of ≤ 60 years patients, and 31 (77.5%) of > 60 years patients. Focal neurological deficit was found in 35 (53%) patients, 11 (42.3%) were ≤ 60 years. The presence of initial neurological symptoms in this study is higher than previously reported, without a difference in age groups, despite the higher somatic burden in the group of patients over 60 years of age.
No takes yet. Share an insight, caveat, or question.
Alexiev et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: